Stanford Healthy Heart Study
Escalating Proportion of Weight-Loss Maintainers Via Modules Prior to Weight Loss
2 other identifiers
interventional
321
1 country
1
Brief Summary
People with elevated blood pressure are at higher risk of having a heart attack or stroke than people with lower blood pressure. Losing a modest amount of weight-such as 15 or 20 pounds-can reduce the risk of having a heart attack or stroke. However, it can often be a struggle to maintain weight loss over time. This study examines whether two behavioral weight-management programs can help people maintain weight loss over time. In this study, 346 adults will be randomly assigned (like flipping a coin) to one of the 12-month programs and followed for 36 months (i.e., 3 years) to see how their body weight may change.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Mar 2017
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2017
CompletedFirst Posted
Study publicly available on registry
January 9, 2017
CompletedStudy Start
First participant enrolled
March 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 27, 2022
CompletedOctober 8, 2025
October 1, 2025
4.9 years
January 2, 2017
October 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of participants who lose a clinically significant amount of initial body weight AND maintain it during the trial (i.e., Lose >=7% of their initial body weight from 0-12 months AND gain <=5 lbs from 12-36 months), assessed by clinic scales
Participants will be weighed during in-person visits at the research clinic at 0, 6, 12, 24, and 36 months
Baseline to 36 months
Secondary Outcomes (2)
Proportion of participants who lose a clinically significant amount of initial body weight AND maintain it during the trial (Lose >=7% of their initial body weight from 0-12 months AND gain <=5 lbs from 12-36 months), assessed by cellular scales
Baseline to 36 months
Change in systolic blood pressure from 0-36 months
Baseline to 36 months
Other Outcomes (9)
Change in self-reported enjoyment of healthy lifestyle behaviors from 0-2 months
Baseline to 2 months
Incremental cost-effectiveness ratio (U.S. Dollars per quality-adjusted life-years) of either weight-management intervention versus no intervention
Baseline to 36 months
Change in self-reported work productivity and activity from 6-36 months
6 to 36 months
- +6 more other outcomes
Study Arms (2)
Fun First
EXPERIMENTALIf randomized to the 12-month Fun First program, participants will attend weekly interactive small-group sessions led by health coaches for 6 months, then receive monthly phone calls from coaches for 6 months. The first 6 months consists of a 2-month module promoting enjoyment of key maintenance skills before losing weight, followed by a 4-month behavioral weight-loss program.
Weight Watchers
ACTIVE COMPARATORIf randomized to the 12-month Weight Watchers program, participants are provided with study-paid access to weekly ongoing Weight Watchers meetings led by peer meeting leaders for 12 months at Weight Watchers locations convenient to participants as well as study-paid access to Weight Watchers personalized online tools. \[The study and investigative team have no financial relationship with Weight Watchers\].
Interventions
Focus on losing weight first via convenient meetings and personalized online tools
Eligibility Criteria
You may qualify if:
- \<= BMI \< 45 kg/m2
- Systolic blood pressure between 120-159 mmHg OR diastolic blood pressure between 80-99 mmHg. Can be on \>=1 antihypertensive medications if on stable dose for past 3 months
- Systolic blood pressure \<120 mmHg OR diastolic blood pressure \<80 mmHg, if on stable dose of \>=1 antihypertensive medications for past 3 months
You may not qualify if:
- Elevated blood pressure: Systolic blood pressure \>=160 mmHg OR diastolic blood pressure \>=100 mmHg
- Have had a heart attack, stroke, coronary heart disease, congestive heart failure, or angina
- Have had coronary artery bypass surgery or cardiac catheterization such as percutaneous transluminal coronary angioplasty (PTCA), cath or stent placement
- Have diabetes
- Have medical contraindications to regular, unsupervised physical activity
- Have moderate to severe asthma, or chronic obstructive pulmonary disorder (also called emphysema or chronic bronchitis)
- Had cancer in the past 5 years (except non-melanoma skin cancer)
- Currently under medical care for digestive issues, gastrointestinal distress, abdominal pain, or diarrhea
- Had an organ transplant
- Not stable on medications over the past 3 months (e.g., cholesterol, thyroid, estrogen-hormone, psychiatric)
- Currently taking prescription pain medications (e.g., Vicodin, Oxycodone)
- Have binge eating disorder or bulimic compensatory symptoms
- Currently taking medication designed to lose weight
- Have undergone weight-loss surgery (e.g., gastric bypass, lap band)
- Have lost \>10 pounds in the past 6 months
- +13 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michaela Kiernan, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Scholar
Study Record Dates
First Submitted
January 2, 2017
First Posted
January 9, 2017
Study Start
March 4, 2017
Primary Completion
January 27, 2022
Study Completion
January 27, 2022
Last Updated
October 8, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
After final quality control and statistical analyses are completed, final project data will be made available to individuals who submit a written data request to the Principal Investigator. This centralized data request process provides a tracking mechanism to inform other external groups about similar analysis activities.